View Older Stories View More Recent Stories

Jan 16, 2015 12:21PM Streetinsider.com's Hot Lunchtime Reads 1/16: (CYTX) (FB) (AAPL) (C) (INTC)

Jan 16, 2015 12:15PM Roth Capital Nearly Doubles PT on Cytori (CYTX) to $6; Positive on Phase III STAR for Scleroderma

Jan 16, 2015 08:11AM Roth Capital Upgrades DepoMed Inc (DEPO) to Buy

Jan 15, 2015 08:24AM Roth Capital Downgrades Nuverra Environmental Solutions (NES) to Neutral

Jan 14, 2015 04:20PM Readout of PRESENTATION I Remains Major Catalyst for BioLineRx (BLRX) in FY15 - Roth Capital

Jan 14, 2015 07:52AM Roth Remains Positive on Pharmacyclics (PCYC) Following Imbruvica Update; Maintains 'Buy' Rating

Jan 13, 2015 06:17AM Lilis Energy (LLEX) Enters $50M Secured Facility

Jan 13, 2015 06:00AM Lilis Energy Secures Credit Facility With Heartland Bank for Up to $50 Million

Jan 12, 2015 07:19AM Roth Capital Downgrades Capstone Turbine (CPST) to Neutral

Jan 9, 2015 09:24AM Verastem's (VSTM) Progress in COMMAND, Other Clinical Programs is 'Impressive' - Roth Capital

Jan 9, 2015 07:25AM 2015 Could be 'Potentially Transformative' Year for GenVec (GNVC); Roth Affirms at 'Buy'

Jan 8, 2015 01:03PM Roth Adjusts Ests on Galena (GALE) Following FY15 Net Revs Outlook; 2015 Will be 'Busy Year' for Company

Jan 8, 2015 09:06AM Stemline Therapeutics (STML) Prices 3.8M Common Offering at $15.75/Share

Jan 8, 2015 09:05AM Stemline Therapeutics Prices $59.85 Million Public Offering of Common Stock

Jan 7, 2015 01:30PM PlacementTracker Publishes 2014 PIPE Market League Tables

Jan 7, 2015 06:57AM Roth Capital Starts Cempra, Inc. (CEMP) at Buy

Jan 6, 2015 02:21PM BioLineRx (BLRX) Continues Executing Well on BL-8040; Roth Capital Affirms at 'Buy'

Jan 6, 2015 01:09PM Unusual 11 Mid-Day Movers 1/6: (MOC) (TNXP) (FRO) Higher; (HGG) (CHOP) (CLDN) Lower

Jan 6, 2015 07:09AM Roth Capital Starts Ellie Mae (ELLI) at Buy

Jan 5, 2015 11:57AM Roth Comments on Pharmacyclics (PCYC) Following Publication on New Imbruvica Data

Jan 5, 2015 11:20AM Roth Capital Updates on Investment Thesis Behind Cytokinetics (CYTK)

Jan 5, 2015 10:41AM Notable Analyst Rating Changes 1/5: (LULU) (SKUL) (INTC) Upgraded; (SKH) (SBUX) (CVC) Downgraded

Jan 5, 2015 09:55AM Notable Mergers and Acquisitions 1/5: (UUUU)/(URZ) (BDC) (DDD) (PFE)

Jan 5, 2015 07:24AM Roth Capital Starts Trecora Resources (TREC) at Buy

Jan 5, 2015 07:13AM Roth Capital Starts Pacific Ethanol (PEIX) at Buy

Jan 5, 2015 07:04AM Roth Capital Starts Green Plains (GPRE) at Buy

Jan 5, 2015 07:02AM Energy Fuels, Inc. (UUUU) to Acquire Uranerz Energy (URZ)

Jan 5, 2015 06:56AM Roth Capital Starts Escalade (ESCA) at Buy

Jan 5, 2015 06:37AM Roth Capital Starts Agios Pharma (AGIO) at Neutral

Dec 31, 2014 01:00PM Unusual 11 Mid-Day Movers 12/31: (NRX) (RDHL) (REN) Higher; (NDRM) (CJJD) (DRAM) Lower

Dec 31, 2014 09:24AM Pre-Open Stock Movers 12/31: (NRX) (RDHL) (MIG) Higher; (NDRM) (GSAT) Lower (more...)

Dec 31, 2014 07:48AM Roth Boosts PT on Cytokinetics (CYTK) to $18; Validation of Partnering Ability is Encouraging

Dec 31, 2014 07:05AM S&W Seed (SANW) Enters $31.7M Conv. Debt, Warrants Private Placement

Dec 30, 2014 05:11PM xG Technology (XGTI) Amends Equity Distribution Agreement with Roth Capital

Dec 29, 2014 08:22AM Roth Capital Lowers PT on Can-Fite BioPharma (CANF) to $20; CF101 Remains Key Catalyst

Dec 29, 2014 07:55AM Bluebird Bio (BLUE) Price Target Raised to $120 at Roth

Dec 26, 2014 02:43PM Roth Positive on Spectrum Pharma (SPPI) Following CE-Melphalan NDA Filing (LGND)

Dec 24, 2014 08:52AM Roth 'Encouraged' by Progress, Biz Development of BioLineRx's (BLRX) BL-5010; Affirms 'Buy' Rating

Dec 23, 2014 02:16PM Keryx Biopharma's (KERX) U.S. Launch of AURYXIA Follows Robust Development Program; Roth Affirms 'Buy' Rating

Dec 23, 2014 02:05PM Roth Affirms Cytokinetics (CYTK) at 'Buy'; Astellas Collaboration Development is Encouraging

Dec 22, 2014 07:07AM Roth Capital Starts Energous Corp (WATT) at Buy

Dec 19, 2014 02:29PM Roth Comments on Ligand Pharma (LGND) Following EU Marketing Authorization of Duavive

Dec 19, 2014 09:51AM Roth Affirms Cytori Therapeutics (CYTX) at 'Buy'; BARDA Affirms Strong Support for Thermal Burn Cell Therapy

Dec 18, 2014 12:25PM LED Lamp sales at Staples.com Will be 'Incremental Positive' for Revolution Lighting (RVLT) - Roth Capital

Dec 18, 2014 10:52AM Roth Capital 'Favorable' on Curis' (CRIS) CUDC-907 Following Phase 1 Initiation in a/r Solid Tumors

Dec 18, 2014 07:22AM Roth Capital Downgrades Volcano Corp. (VOLC) to Neutral

Dec 17, 2014 05:00PM MEI Pharma (MEIP) Completes 10M Common Offering

Dec 17, 2014 09:15AM New DoC Antidumping Tariffs Worse-than-Expected for Most Chinese Producers - Roth (TSL) (JASO) (SCTY)

Dec 17, 2014 06:56AM Roth Capital Starts Barracuda Networks (CUDA) at Buy

Dec 16, 2014 07:20AM Roth Capital Still Positive on Celldex (CLDX) Upon Completion of Phase III ACT IV Enrollment

View More Recent Stories View Older Stories